Related Experiment Video
Updated: May 31, 2026
09:58
DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
Published on: June 6, 2025
A methodology for utilization of predictive genomic signatures in FFPE samples
Jennifer A Freedman1, Christina K Augustine, Angelica M Selim
1Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27708, USA.
BMC Medical Genomics
|July 13, 2011
Summary
Gene expression signatures from formalin-fixed, paraffin-embedded (FFPE) tumor tissues reliably predict oncogenic pathway activity. This enables broader genomic analysis for understanding disease and guiding cancer therapy selection.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Gene expression signatures identify oncogenic pathway activity, aiding tumor heterogeneity analysis and predicting drug sensitivity.
- Utilizing formalin-fixed, paraffin-embedded (FFPE) tissues is crucial for widespread clinical application of these signatures.
Purpose of the Study:
- To evaluate the reliability of gene expression profiling from FFPE tissues for predicting oncogenic pathway activity.
- To assess the consistency of pathway activity predictions between fresh-frozen and FFPE tumor samples.
Main Methods:
- MessageAmp Premier methodology and Affymetrix arrays were used to generate pathway activity data from FFPE and fresh-frozen xenograft tumor samples.
- Gene expression data from matched patient FFPE and fresh-frozen melanomas were analyzed for consistency.
Main Results:
- Significant correlation was found between pathway activity predictions from paired fresh-frozen and FFPE xenograft samples.
- High concordance was observed in pathway activity predictions between matched patient fresh-frozen and FFPE melanoma samples.
Conclusions:
- FFPE tumor tissues can yield reliable and consistent predictions of oncogenic pathway activities.
- The use of FFPE tissues for genomic analysis enhances understanding of disease progression and supports personalized therapeutic strategies.
